It was yesterday. There is a topic on it from yesterday and a few folks posted notes, including me. I just listened to it again and noticed Uli said the -020 trial showd success with hallucinations and delusions. I believe delusions is associated with PDP and ADP where as hallucinations is associated with schizo. I am not positive, so someone correct me if I am wrong.
I never really heard them say it was successful against hallucinations before until this conference, so this seems to be consistent with their recent comments about the possibility of a standalone trial for schizo rather than a co-therapy.
are you nuts, this was a great placement timing by the underwriters. The stock was low $20'sabout 2 weeks ago. I will note, they were well paid for thei work, taking $1.71 per share as an underwriting fee. The net take by the company was $28.5 - the fee, just under $27.